Fairscale Capital »

Abbvie shares owned by Fairscale Capital

Quarter-by-quarter ownership of Abbvie (ABBV) shares owned by Fairscale Capital from 13F filings

Historical chart of Fairscale Capital investment in Abbvie

Tip: Access up to 7 years of quarterly data

All positions including Abbvie held by Fairscale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abbvie by Fairscale Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $100k 508 197.33
2024-06-30 $86k 508 169.07

More positions owned by Fairscale Capital

Vanguard S&p 500 Etf idx (VOO)
iShares S&P NA Tech. Sec. Idx (IGM)
NVIDIA Corporation (NVDA)
Vanguard Admiral Fds Inc equity (VOOV)
Apple (AAPL)
Pacer Fds Tr us cash cows 100 (COWZ)
Microsoft Corporation (MSFT)
Invesco Qqq Trust Series 1 (QQQ)
Visa (V)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Schwab Strategic Tr us dividend eq (SCHD)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Facebook Inc cl a (META)

View all positions for Fairscale Capital

Top funds holding Abbvie

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Morgan Stanley
Geode Capital Management
Charles Schwab Investment Management
Bank of America Corporation
Bank of New York Mellon
Franklin Resources
Goldman Sachs Group
Henderson Group
T. Rowe Price Associates
Nuveen Asset Management
Wells Fargo & Company

View all funds holding Abbvie